Anthony Rogers
Interventional Pain Medicine · Boynton Beach, FLNPI 1114938586
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.8% of the total across 417 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations.
Across 417 payments — averaging $31.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2K
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$1K
- Medtronic$1K
- Collegium Pharmaceutical, Inc.$1K
- Daiichi Sankyo Inc.$827
- plus $6K from 35 others
Across 15 payments — averaging $5709.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GRT US Holding, Inc.$46K
- Flowonix Medical Incorporated$37K
- Hikma Pharmaceuticals USA$749
- Purdue Pharma L.p.$749
- Endo Pharmaceuticals Inc.$680
What the payments were for
- Consulting fees$430%
- Travel & lodging$1,0018%
- Food & beverage$11,87792%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$981
- UBRELVY$846
- QULIPTA$599
- INTELLIS ADAPTIVESTIM$320
- Morphabond ER$246
- QUVIVIQ$245
- Blackhawk Cervical Spacer System$153
- Boomerang$153
- TIGERSHARK C$153
- Harrier SA Lumbar Interbody System$153
- Stratofuse$153
- INTELLIS$127
- INCEPTIV$123
- Dayvigo$121
- Iovera$107
- Zilretta$107
- EXPAREL$101
- OSTEOCOOL RF ABLATION SYSTEM$101
How this compares
$12,931 in reported general payments places this provider in the 75th percentile of 278 interventional pain medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 14 | $29,565 |
| MovantikNaloxegol Oxalate | 16 | $6,504 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $1,637 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $1,360 |
| Oxycodone Hcl | 22 | $1,121 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $881 |
| Morphine Sulfate | 16 | $554 |
| Tizanidine Hcl | 47 | $466 |
| Pregabalin | 28 | $465 |
| Celecoxib | 35 | $303 |
| Gabapentin | 29 | $261 |
| Tramadol Hcl | 17 | $231 |
| Cyclobenzaprine Hcl | 23 | $186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $76 | $6,50416 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $35 | $55416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Boynton Beach
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.